[1] L. Mazzola, Commercializing nanotechnology, Nat. Biotechnol. 21 (2003) 1137–1143. doi:10.1038/nbt1003-1137.
[2] R. Paull, J. Wolfe, P. Hébert, M. Sinkula, Investing in nanotechnology, Nat. Biotechnol. 21 (2003) 1144–1147. doi:10.1038/nbt1003-1144.
[3] O. Salata, Applications of nanoparticles in biology and medicine, J. Nanobiotechnology. 2 (2004) 3. doi:10.1186/1477-3155-2-3.
[4] Y. Liu, H. Miyoshi, M. Nakamura, Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles, Int. J. Cancer. 120 (2007) 2527–2537. doi:10.1002/ijc.22709.
[5] R. Seigneuric, L. Markey, D.S.A. Nuyten, C. Dubernet, C.T.A. Evelo, E. Finot, C. Garrido, From nanotechnology to nanomedicine: applications to cancer research, Curr. Mol. Med. 10 (2010) 640–652.
[6] G.M. Whitesides, The “right” size in nanobiotechnology, Nat. Biotechnol. 21 (2003) 1161–1165. doi:10.1038/nbt872.
[7] A.C. Talleur, F. Navid, S.L. Spunt, M.B. McCarville, J. Wu, S. Mao, A.M. Davidoff, M.D. Neel, M.J. Krasin, Limited Margin Radiation Therapy for Children and Young Adults With Ewing Sarcoma Achieves High Rates of Local Tumor Control, Int. J. Radiat. Oncol. Biol. Phys. 96 (2016) 119–126. doi:10.1016/j.ijrobp.2016.04.001.
[8] M.K. Angele, M. Albertsmeier, N.J. Prix, P. Hohenberger, S. Abdel-Rahman, N. Dieterle, M. Schmidt, U. Mansmann, C.J. Bruns, R.D. Issels, K.-W. Jauch, L.H. Lindner, Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter study, Ann. Surg. 260 (2014) 749–754; discussion 754-756. doi:10.1097/SLA.0000000000000978.
[9] N. Nishiyama, M. Yokoyama, T. Aoyagi, T. Okano, Y. Sakurai, K. Kataoka, Preparation and Characterization of Self-Assembled Polymer−Metal Complex Micelle from cis -Dichlorodiammineplatinum(II) and Poly(ethylene glycol)−Poly( α ,β-aspartic acid) Block Copolymer in an Aqueous Medium, Langmuir. 15 (1999) 377–383. doi:10.1021/la980572l.
[10] X. Duan, C. He, S.J. Kron, W. Lin, Nanoparticle formulations of cisplatin for cancer therapy, Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 8 (2016) 776–791. doi:10.1002/wnan.1390.
[11] S. Dhar, N. Kolishetti, S.J. Lippard, O.C. Farokhzad, Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo, Proc. Natl. Acad. Sci. U. S. A. 108 (2011) 1850–1855. doi:10.1073/pnas.1011379108.
[12] S. Aryal, C.-M.J. Hu, L. Zhang, Polymer-Cisplatin Conjugate Nanoparticles for Acid-Responsive Drug Delivery, ACS Nano. 4 (2010) 251–258. doi:10.1021/nn9014032.
[13] H. Ye, L. Jin, R. Hu, Z. Yi, J. Li, Y. Wu, X. Xi, Z. Wu, Poly(gamma,L-glutamic acid)-cisplatin conjugate effectively inhibits human breast tumor xenografted in nude mice, Biomaterials. 27 (2006) 5958–5965. doi:10.1016/j.biomaterials.2006.08.016.
[14] F. Zhao, Y. Zhao, Y. Liu, X. Chang, C. Chen, Y. Zhao, Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials, Small Weinh. Bergstr. Ger. 7 (2011) 1322–1337. doi:10.1002/smll.201100001.
[15] N.-V. Cuong, J.-L. Jiang, Y.-L. Li, J.-R. Chen, S.-C. Jwo, M.-F. Hsieh, Doxorubicin-Loaded PEG-PCL-PEG Micelle Using Xenograft Model of Nude Mice: Effect of Multiple Administration of Micelle on the Suppression of Human Breast Cancer, Cancers. 3 (2010) 61–78. doi:10.3390/cancers3010061.
[16] H.YasudaY.Iriyama, Plasma Polymerization, in: Compr. Polym. Sci. Suppl., University of Missouri-Rolla, Rolla, MO, USA, 1989: pp. 357–375.
[17] S. Bhatt, J. Pulpytel, G. Ceccone, P. Lisboa, F. Rossi, V. Kumar, F. Arefi-Khonsari, Nanostructure Protein Repellant Amphiphilic Copolymer Coatings with Optimized Surface Energy by Inductively Excited Low Pressure Plasma, (2011). doi:10.1021/la203256w.
[18] S. Bhatt, J. Pulpytel, F. Arefi-Khonsari, Low and atmospheric plasma polymerisation of nanocoatings for bio-applications, Surf. Innov. 3 (2015) 63–83. doi:10.1680/sufi.14.00008.
[19] F. Khelifa, S. Ershov, Y. Habibi, R. Snyders, P. Dubois, Free-Radical-Induced Grafting from Plasma Polymer Surfaces, Chem. Rev. 116 (2016) 3975–4005. doi:10.1021/acs.chemrev.5b00634.
[20] B. S, P. J, M. M, A.-K. F, Plasma co-polymerized nano coatings - As a biodegradable solid carrier for tunable drug delivery applications, Polymer. 54 (2013) 4820–4829.
[21] S. Bhatt, J. Pulpytel, M. Mirshahi, F. Arefi-Khonsari, Nano thick poly(ε-caprolactone)-poly(ethylene glycol) coatings developed by catalyst-free plasma assisted copolymerization process for biomedical applications, RSC Adv. 2 (2012) 9114–9123. doi:10.1039/C2RA21211K.
[22] S. Bhatt, F. Valamanesh, J. Pulpytel, R. Lo Dico, A. Baiyukha, I. Al-Dybiat, M. Pocard, F. Arefi-Khonsari, M. Mirshahi, Radio-frequency plasma polymerized biodegradable carrier for in vivo release of cis-platinum, Oncotarget. 7 (2016) 58121–58132. doi:10.18632/oncotarget.10932.
[23] A. Baitukha, I. Al-Dybiat, A. Valinataj-Omran, J. Pulpytel, M. Pocard, M. Mirsha’shi, F. Arefi-Khonsari, Low Pressure Plasma Processing of Collagen Membranes for Anti-Cancer Drug Delivery, J. Mater. Sci. Eng. 7 (2018) 1–6. doi:10.4172/2169-0022.1000499.
[24] The width of resection margins influences local recurrence in soft tissue sarcoma patients - European Journal of Surgical Oncology, (n.d.). https://www.ejso.com/article/S0748-7983(16)30040-3/fulltext (accessed December 10, 2018).
[25] J.B. Shewale, K.G. Mitchell, D.B. Nelson, A.P. Conley, D.C. Rice, M.B. Antonoff, W.L. Hofstetter, G.L. Walsh, S.G. Swisher, J.A. Roth, R.J. Mehran, A.A. Vaporciyan, A. Weissferdt, B. Sepesi, Predictors of survival after resection of primary sarcomas of the chest wall-A large, single-institution series, J. Surg. Oncol. 118 (2018) 518–524. doi:10.1002/jso.25162.
[26] J. Zhou, K.-B. Atsina, B.T. Himes, G.W. Strohbehn, W.M. Saltzman, Novel Delivery Strategies for Glioblastoma, Cancer J. Sudbury Mass. 18 (2012). doi:10.1097/PPO.0b013e318244d8ae.
[27] C. Bastiancich, P. Danhier, V. Préat, F. Danhier, Anticancer drug-loaded hydrogels as drug delivery systems for the local treatment of glioblastoma, J. Controlled Release. 243 (2016) 29–42. doi:10.1016/j.jconrel.2016.09.034.